Skip to main content

Table 3 Multivariate Cox model for DDFS (n = 170) and OS (n = 174)

From: Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

OutcomeMV analysis of DDFS with nodal statusMV analysis of OS with nodal status
HR (95% CI)p valueHR (95% CI)p value
Age at initial diagnosis1.01 (0.98, 1.04)0.66081.03 ( 0.99, 1.07)0.1252
Chemotherapy given in the first year following diagnosis0.42 (0.11, 1.65)0.21290.71 ( 0.16, 3.21)0.6552
Metaplastic diagnosis1.64 (0.75, 3.58)0.21591.64 ( 0.69, 3.90)0.2597
Positive nodes4.32 (1.66, 11.29)0.00282.62 ( 0.88, 7.82)0.0844
Radiotherapy given0.58 (0.23, 1.50)0.26430.55 ( 0.20, 1.49)0.2384
Stage 10.33 (0.06, 1.83)0.02870.06 ( 0.01, 0.54)0.0021
Stage 20.32 (0.14, 0.74)0.07 ( 0.02, 0.28)
Stage 3Ref0.24 ( 0.06, 0.93)
Stage 4Ref
  1. Abbreviations: CI = confidence interval; DDFS = distant disease-free survival; HR = hazard ratio; MV = multivariate; OS = overall survival